Trials / Completed
CompletedNCT04037904
Long-term Follow-up of Interleukin-1B and H+,K+-ATPase mRNA Expression After Helicobacter Pylori Eradication
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 490 (actual)
- Sponsor
- Seoul National University Bundang Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
We will evaluate the long-term changes of gastric H+, K+-adenosine triphosphatase (H+, K+-ATPase) and Interleukin-1B mRNA expression according to Helicobacter pylori (H.pylori) infection and intestinal metaplasia and investigate the long-term effect of H. pylori eradication
Detailed description
H. pylori suppresses gastric acid secretion by repressing gastric acid pump, H+, K+-ATPase, and stimulating Interleukin-1B. In this study, we will evaluate the expression of H+, K+-ATPase and Interleukin-1B mRNA according to H. pylori infection and intestinal metaplasia in controls and patients with gastric cancer. In addition, we observe the changes of H+, K+-ATPase and Interleukin-1B mRNA expression over 5 years after H. pylori eradication.
Conditions
Timeline
- Start date
- 2006-02-01
- Primary completion
- 2022-01-01
- Completion
- 2022-12-01
- First posted
- 2019-07-30
- Last updated
- 2023-04-13
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04037904. Inclusion in this directory is not an endorsement.